Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis - Experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil

Citation
Mb. Conde et al., Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis - Experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil, AM J R CRIT, 162(6), 2000, pp. 2238-2240
Citations number
13
Categorie Soggetti
Cardiovascular & Respiratory Systems","da verificare
Journal title
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN journal
1073449X → ACNP
Volume
162
Issue
6
Year of publication
2000
Pages
2238 - 2240
Database
ISI
SICI code
1073-449X(200012)162:6<2238:COSIWF>2.0.ZU;2-S
Abstract
Many patients with suspected pulmonary tuberculosis (PTB) do not produce sp utum spontaneously or are smear-negative for acid-fast bacilli (AFB). We pr ospectively compared the yield of sputum induction (SI) and fiberoptic bron choscopy with bronchoalveolar lavage (BAL) for the diagnosis of PTB in a re gion with a high prevalence of tuberculosis and human immunodeficiency viru s (HIV) infection. Fifty seven percent (143 of 251) of patients had diagnos es of PTB, of whom 17% (25 of 143) were HIV seropositive. There were no sig nificant differences in the yields of AFB smears or cultures whether obtain ed via SI or BAL Among 207 HIV-seronegative patients, the AFB smear and myc obacterial culture results from specimens obtained by SI and BAL were in ag reement in 97% (202 of 207) (kappa test = 0.92) and 90% (186 of 207) (kappa test = 0.78), respectively. Among HIV-seropositive patients the agreements between AFB smear and culture results for SI and BAL specimens were 98% (4 3 of 44) (kappa test = 0.93) and 86% (38 of 44) (kappa test = 0.69), respec tively. We conclude that SI is a safe procedure with a high diagnostic yiel d and high agreement with the results of fiberoptic bronchoscopy for the di agnosis of PTB in both HIV-seronegative and HIV-seropositive patients.